Evidence map›Paper›PMID 36824495›Full record

ArticleFrontiers in surgery2023

The safe and effective use of supercritical CO

Nicolas Aurouer, Patrick Guerin, Arnaud Cogniet, Morad Pedram

Abstract read
In one paragraph

Article in Frontiers in surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Satisfactory long-term clinical and radiographic outcomes using supercritical COEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicolas AurouerCentre Aquitain du dos, Clinique du Sport de Bordeaux, 2 rue Georges-Negrevergne, Mérignac, France.
Patrick GuerinCentre Aquitain du dos, Clinique du Sport de Bordeaux, 2 rue Georges-Negrevergne, Mérignac, France.
Arnaud CognietCentre Aquitain du dos, Clinique du Sport de Bordeaux, 2 rue Georges-Negrevergne, Mérignac, France.
Morad PedramCentre Aquitain du dos, Clinique du Sport de Bordeaux, 2 rue Georges-Negrevergne, Mérignac, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The clinical efficacy and safety of supercritical CO Methods: Sixteen patients underwent one or two level anterior cervical discectomy and fusion and 37 patients underwent anterior retroperitoneal route lumbar fusion using bone allografts processed using supercritical CO Results: At a mean of 43 and 47 months postoperatively, 95.3% and 90.5% of cervical and lumbar fusion patients had radiographic evidence of bone fusion, respectively. Over 80% of patients reported good to excellent outcomes according to Odom's criteria, the perception of pain significantly decreased, and the mean NDI and ODI scores significantly improved at the last follow-up compared with before the operations. There were no safety concerns. For the cervical group, the mean NDI score improved from 26.3 ± 6.01 preoperatively to 15.00 ± 8.03 and 17.60 ± 13.95 at immediate post-op ( Conclusion: Within the limitations of this study, the use of supercritical CO

Indexed as

anterior cervical decompression and fusionanterior lumbar interbody fusionbone allograftcervical and lumbar fusionsupercritical CO2 treated bone

Identifiers

PMID36824495
PMCPMC9941326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.